Research Team

Theralase has a unique combination of scientific capabilities in medical devises and small light-activated molecules discovery, design and development. This puts us in a strong position to develop the targeted innovative, science based, medical technology platforms required to meet patient needs. To increase the value of our pipeline we are not only applying the best science and technology, but also employing a comprehensive strategy to safeguard our intellectual property through patent protection.

Arkady Mandel, MD, Ph.D., D.Sc.

Chief Scientific Officer
21+ years experience as a key founder of therapeutic uses of lasers in dermatology and other areas of clinical medicine.

Lothar Lilge PhD

Scientific Principal Investigator
Professor in the Department of Medical Biophysics at the University of Toronto, Senior Scientist Ontario Cancer Institute, Princess Margaret Cancer Center

Pavel Kaspler, PhD

Research Scientist

Savo Lazic, PhD

Research Scientist

Manjunatha Munegowda DVM, MS, PhD

Research Scientist
Cancer Therapy- Immunotherapy

Mark Roufaiel PhD

Research Scientist
Immunolgy & Cardiovascular Biology
 

Innovative Technology

 

Scientific and Medical Advisory Board

Our Scientific and Medical Advisory Board (SMAB) is comprised of international key opinion leaders and esteemed scientists with broad expertise in biomedical and clinical research, drug discovery and development, as well as, medical device engineering and manufacturing. The SMAB plays an active role in Theralase pipeline's development with evaluation of in-licensing and partnership opportunities. The SMAB members meet regularly with the Theralase team to maximize the chances of success of each of Theralase's TLT and PDT operational divisions platform technology pipelines. Together, members of the Scientific and Medical Advisory Board provide critical evaluation and guidance of our proposed and current programmes to ensure that our research is focused and cutting-edge. 

James Andrews MD (ASMI)

American Sports Medicine Institute Chair and Medical Director, Founder and Orthopedic Surgeon.

Dr. Jeffrey Dugas

American Academy of Orthopedic Surgeons, ASMI, International Cartilage Repair Society

Dr. Kevin Wilk

American Physical Therapy Association, ASMI

Dr. Lyle Cain

American Orthopaedic Society for Sports Medicine, ASMI, ICRS

Michael Jewett MD

Professor of Surgery (Urology) at Univ. of Toronto, Surgical Oncology at Princess Margaret Cancer Centre

Lothar Lilge PhD

Scientific Principal Investigator
Professor in the Department of Medical Biophysics at the University of Toronto, Senior Scientist Ontario Cancer Institute, Princess Margaret Cancer Center

Pavel Kaspler, PhD

Research Scientist

Savo Lazic, PhD

Research Scientist

Ashish M. Kamat

MD, MBBS, FACS
Dr Kamat is an internationally recognized expert in urologic oncology and an authority in the management of urologic cancers.

Dr. Michael A. O’Donnell

MD, Professor of Urology, University of Iowa
Dr. O’Donnell’s basic and clinical research has a long history of focusing on bladder immunology and bladder cancer immunotherapy

Brian C. Wilson, Ph.D

Dr. Wilson is a Senior Scientist and Head of the Applied Biophotonics group at Princess Margaret Cancer Centre, University Health Network and Professor in the Department of Medical Biophysics at…

Manjunatha Munegowda DVM, MS, PhD

Research Scientist
Cancer Therapy- Immunotherapy